Gregory M. Chen
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Physiology top 5%
Papers in
- Oncology 12
- CAR-T cell therapy research 11
-
- Immune Cell Function and Interaction 3
- Co-authors
- Deena M.A. Gendoo (3 shared papers)Benjamin Haibe‐Kains (3 shared papers)Kai Tan (5 shared papers)Nathan A. Magarvey (2 shared papers)Chad W. Johnston (2 shared papers)Chris A. Dejong (2 shared papers)Michael A. Skinnider (2 shared papers)Yangyang Ding (3 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Nature Biomedical Engineering (2 papers)Nature Chemical Biology (2 papers)Nature (2 papers)Nature Genetics (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Gregory M. Chen
24 papers receiving 2.2k citations
Gregory M. Chen's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.1k
- Physiology 125
- Immunology 487
- Cancer Research 298
- Molecular Biology 750
Countries citing papers authored by Gregory M. Chen
This map shows the geographic impact of Gregory M. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Chen more than expected).
Fields of papers citing papers by Gregory M. Chen
This network shows the impact of papers produced by Gregory M. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Chen. The network helps show where Gregory M. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory M. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Decade-long leukaemia remissions with persistence of CD4+ CAR T cells Hit paper breakdown → | 2022 | 711 |
| 2 | 2015 | 387 | |
| 3 | 2015 | 225 | |
| 4 | 2021 | 163 | |
| 5 | FOXO1 is a master regulator of memory programming in CAR T cells Hit paper breakdown → | 2024 | 141 |
| 6 | 2016 | 112 | |
| 7 | 2018 | 104 | |
| 8 | 2016 | 95 | |
| 9 | 2016 | 88 | |
| 10 | 2019 | 66 | |
| 11 | 2019 | 31 | |
| 12 | 2020 | 23 | |
| 13 | 2016 | 22 | |
| 14 | 2024 | 16 | |
| 15 | 2022 | 15 | |
| 16 | 2024 | 15 | |
| 17 | 2021 | 14 | |
| 18 | 2019 | 12 | |
| 19 | 2026 | 6 | |
| 20 | 2022 | 5 |
About Gregory M. Chen
Gregory M. Chen is a scholar working on Oncology, Immunology, Hematology, Public Health, Environmental and Occupational Health and Cancer Research, having authored 24 papers that have together received 2.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Cancer Genomics and Diagnostics (3 papers), Molecular Biology Techniques and Applications (3 papers), Immune Cell Function and Interaction (3 papers), Microbial Natural Products and Biosynthesis (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (1.1k citations), Physiology (125 citations), Immunology (487 citations), Cancer Research (298 citations) and Molecular Biology (750 citations). Gregory M. Chen has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Deena M.A. Gendoo, Benjamin Haibe‐Kains, Kai Tan, Nathan A. Magarvey, Chad W. Johnston, Chris A. Dejong, Michael A. Skinnider, Yangyang Ding, David Maxwell Barrett and Stephan A. Grupp. Their work appears in journals such as Clinical Cancer Research, Nature Biomedical Engineering, Nature Chemical Biology, Nature and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.